• 1
    Steel DM, Whitehead AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:8188.
  • 2
    Pepys MB, Dash AC, Markham RE, Thomas HC, Williams BD, Petrie A (1978) Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol 32:119124.
  • 3
    Du Clos TW, Mold C (2001) The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 14:289293.
  • 4
    Pepys MB, Baltz M, Gomer K, Davies AJ, Doenhoff M (1979) Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278:259261.
  • 5
    Butler PJ, Tennent GA, Pepys MB (1990) Pentraxin-chromatin interactions: serum amyloid P component specifically displaces H1-type histones and solubilizes native long chromatin. J Exp Med 172:1318.
  • 6
    Du Clos TW, Zlock LT, Marnell L (1991) Definition of a C-reactive protein binding determinant on histones. J Biol Chem 266:21672171.
  • 7
    Du Clos TW, Zlock LT, Rubin RL (1988) Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 141:42664270.
  • 8
    Marnell L, Mold C, Du Clos TW (2005) C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol 117:104111.
  • 9
    Thompson D, Pepys MB, Wood SP (1999) The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 7:169177.
  • 10
    Volanakis JE, Kaplan MH (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 136:612614.
  • 11
    Garlanda C, Bottazzi B, Salvatori G, De Santis R, Cotena A, Deban L, Maina V, Moalli F, Doni A, Veliz-Rodriguez T, Mantovani A (2006) Pentraxins in innate immunity and inflammation. Novartis Found Symp 279:8086.
  • 12
    Mold C, Gurule C, Otero D, Du Clos TW (1996) Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1. Clin Immunol Immunopathol 81:153160.
  • 13
    Kaplan MH, Volanakis JE (1974) Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 112:21352147.
  • 14
    Emsley J, White HE, O'Hara BP, Oliva G, Srinivasan N, Tickle IJ, Blundell TL, Pepys MB, Wood SP (1994) Structure of pentameric human serum amyloid P component. Nature 367:338345.
  • 15
    Shrive AK, Cheetham GM, Holden D, Myles DA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ (1996) Three dimensional structure of human C-reactive protein. Nat Struct Biol 3:346354.
  • 16
    Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW (1999) The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 190:585590.
  • 17
    Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW (1995) C-reactive protein binds to Fc gamma RI in transfected COS cells. J Immunol 155:21852193.
  • 18
    Lu J, Marnell LL, Marjon KD, Mold C, Du Clos TW, Sun PD (2008) Structural recognition and functional activation of FcgammaR by innate pentraxins. Nature 456:989992.
  • 19
    Daeron M (1997) Fc receptor biology. Annu Rev Immunol 15:203234.
  • 20
    Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD (2001) The structure of a human type III Fcgamma receptor in complex with Fc. J Biol Chem 276:1646916477.
  • 21
    Lu J, Marjon KD, Marnell LL, Wang R, Mold C, Du Clos TW, Sun P (2011) Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc Natl Acad Sci USA 108:49744979.
  • 22
    Monteiro RC, Kubagawa H, Cooper MD (1990) Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans. J Exp Med 171:597613.
  • 23
    Monteiro RC, Van De Winkel JG (2003) IgA Fc receptors. Annu Rev Immunol 21:177204.
  • 24
    Herr AB, Ballister ER, Bjorkman PJ (2003) Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423:614620.
  • 25
    Zhang W, Bi B, Oldroyd RG, Lachmann PJ (2000) Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a. Clin Exp Immunol 121:106111.
  • 26
    Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM (2001) The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 166:17811789.
  • 27
    Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM (1999) Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. J Immunol 162:21462153.
  • 28
    Lu J, Ellsworth JL, Hamacher N, Oak SW, Sun PD (2011) Crystal structure of Fcgamma receptor I and its implication in high affinity gamma-immunoglobulin binding. J Biol Chem 286:4060840613.
  • 29
    Ramsland PA, Farrugia W, Bradford TM, Sardjono CT, Esparon S, Trist HM, Powell MS, Tan PS, Cendron AC, Wines BD, Scott AM, Hogarth PM (2011) Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes. J Immunol 187:32083217.
  • 30
    Du Clos TW, Marnell L, Zlock LR, Burlingame RW (1991) Analysis of the binding of C-reactive protein to chromatin subunits. J Immunol 146:12201225.
  • 31
    Yang M, Xu G, Li S, Sun L, Shi N, Zeng W, Pang H, Zhang W, Roa Z (2003) Crystallization and preliminary crystallographic analysis of the extracellular fragment of FcalphaRI/CD89. Acta Crystallogr D59:22512253.